文献速递心力衰竭与心肌病心律失常

RBM20突变导致与钙处理紊乱相关的心律失常性扩张型心肌病

RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.
PubMed 文献 · Circulation · 2018-01-01

研究比较RBM20与TTN突变携带者的临床特征,并利用Rbm20敲除小鼠探索分子机制。RBM20突变携带者持续性室性心律失常发生率显著高于TTN突变携带者(44% vs 5%,P=0.006)。Rbm20缺失导致CamkIIδ异常剪接并向δ-A亚型偏移,增加L型钙电流、细胞内钙超载和肌浆网钙含量,促进致心律失常性钙释放,而维拉帕米可减轻该现象。

要点

  • RBM20突变携带者持续性室性心律失常风险显著高于TTN突变携带者(44% vs 5%,P=0.006)。
  • Rbm20缺失通过CamkIIδ异常剪接增加L型钙电流和肌浆网钙释放,导致心律失常。
  • L型钙通道拮抗剂维拉帕米可减轻Rbm20缺失心肌细胞的自发性钙释放。

核心结论

  • RBM20缺失通过扰乱钙处理导致更多致心律失常性肌浆网钙释放,RBM20突变携带者室性心律失常风险高于TTN突变携带者,可能从L型钙通道阻滞剂治疗中获益。

研究设计与样本

  • 比较RBM20与TTN突变携带者的临床特征,并使用既往建立的Rbm20敲除小鼠进行细胞电生理和钙测量。

主要发现

  • RBM20突变携带者持续性室性心律失常发生率高于TTN突变携带者(44% vs 5%,P=0.006)。
  • Rbm20敲除小鼠中影响钙和离子处理基因的剪接事件富集,尤其是CamkIIδ和RyR2。
  • Rbm20敲除小鼠CamkIIδ异常剪接向δ-A亚型偏移,增加L型钙电流、细胞内钙超载和肌浆网钙含量。
  • 完全或杂合缺失Rbm20均增加自发性肌浆网钙释放,维拉帕米可减轻。

临床怎么用

  • RBM20突变携带者即使左心室功能相似,仍应警惕室性心律失常风险,L型钙通道阻滞剂可能减少心律失常负荷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mutations in RBM20 (RNA-binding motif protein 20) cause a clinically aggressive form of dilated cardiomyopathy, with an increased risk of malignant ventricular arrhythmias. RBM20 is a splicing factor that targets multiple pivotal cardiac genes, such as Titin (TTN) and CAMK2D (calcium/calmodulin-dependent kinase II delta). Aberrant TTN splicing is thought to be the main determinant of RBM20-induced dilated cardiomyopathy, but is not likely to explain the increased risk of arrhythmias. Here, we investigated the extent to which RBM20 mutation carriers have an increased risk of arrhythmias and explore the underlying molecular mechanism. METHODS: We compared clinical characteristics of RBM20 and TTN mutation carriers and used our previously generated Rbm20 knockout (KO) mice to investigate downstream effects of Rbm20-dependent splicing. Cellular electrophysiology and Ca2+ measurements were performed on isolated cardiomyocytes from Rbm20 KO mice to determine the intracellular consequences of reduced Rbm20 levels. RESULTS: Sustained ventricular arrhythmias were more frequent in human RBM20 mutation carriers than in TTN mutation carriers (44% versus 5%, respectively, P=0.006). Splicing events that affected Ca2+- and ion-handling genes were enriched in Rbm20 KO mice, most notably in the genes CamkIIδ and RyR2. Aberrant splicing of CamkIIδ in Rbm20 KO mice resulted in a remarkable shift of CamkIIδ toward the δ-A isoform that is known to activate the L-type Ca2+ current ( ICa,L). In line with this, we found an increased ICa,L, intracellular Ca2+ overload and increased sarcoplasmic reticulum Ca2+ content in Rbm20 KO myocytes. In addition, not only complete loss of Rbm20, but also heterozygous loss of Rbm20 increased spontaneous sarcoplasmic reticulum Ca2+ releases, which could be attenuated by treatment with the ICa,L antagonist verapamil. CONCLUSIONS: We show that loss of Rbm20 disturbs Ca2+ handling and leads to more proarrhythmic Ca2+ releases from the sarcoplasmic reticulum. Patients that carry a pathogenic RBM20 mutation have more ventricular arrhythmias despite a similar left ventricular function, in comparison with patients with a TTN mutation. Our experimental data suggest that RBM20 mutation carriers may benefit from treatment with an ICa,L blocker to reduce their arrhythmia burden.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. van den Hoogenhof MMG, Beqqali A, Amin AS, et al. RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling. Circulation. 2018. PMID: 29650543. doi:10.1161/CIRCULATIONAHA.117.031947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。